Title: The HbA1c/HDL-C Ratio as a Screening indicator of NAFLD in U.S. Adults:A Cross-
sectional NHANES Analysis (2017–2020)
Version: 3 Date: 15 Apr 2025
Reviewer:  Anwar Ashraf Abouelnasr
Reviewer's report:
The authors have provided comprehensive and thoughtful responses to all reviewer comments.
They have made appropriate revisions, acknowledged key limitations, and contextualized their
findings carefully. While the lack of a significant association between the HbA1c/HDL-C ratio
and liver fibrosis remains a limitation.
Title: The HbA1c/HDL-C Ratio as a Screening indicator of NAFLD in U.S. Adults:A Cross-
sectional NHANES Analysis (2017–2020)
Version: 3 Date: 15 Apr 2025
Reviewer:  Anwar Ashraf Abouelnasr
Reviewer's report:
The authors have provided comprehensive and thoughtful responses to all reviewer comments.
They have made appropriate revisions, acknowledged key limitations, and contextualized their
findings carefully. While the lack of a significant association between the HbA1c/HDL-C ratio
and liver fibrosis remains a limitation.
Please review this paper.
user
Title: The HbA1c/HDL-C Ratio as a Screening indicator of NAFLD in U.S. Adults:A Cross-
sectional NHANES Analysis (2017–2020)
Version: 3 Date: 15 Apr 2025
Reviewer:  Anwar Ashraf Abouelnasr
Reviewer's report:
The authors have provided comprehensive and thoughtful responses to all reviewer comments.
They have made appropriate revisions, acknowledged key limitations, and contextualized their
findings carefully. While the lack of a significant association between the HbA1c/HDL-C ratio
and liver fibrosis remains a limitation.
assistant